• Drug Discovery Research
  • Immunotherapy Research
  • Antibody Engineering Research
Creative Biolabs Blog

Menu

Skip to content
  • Drug Discovery Research
  • Immunotherapy Research
  • Antibody Engineering Research

Category Archives: Drug Discovery Research

29Mar/18
new models to identify genetic targets and test promising treatments in adrenal cancer.

New Model, New drugs, and A ‘Remarkable’ Response in Adrenal Cancer

March 29, 2018Drug Discovery Research, Immunotherapy Research, NewsAntibody Discovery, genetic targets, humanized mouse modelbiolabs

“Two new studies use new models to identify genetic targets and test promising treatments for adrenal cancer. One patient was treated with the immunotherapy pembrolizumab and now more than a year afterRead More…

29Mar/18
2006-2017 CBER Approved Therapies and Biological Products

Cancer Drug R&D and Market Trends from 2006 to 2017

March 29, 2018Drug Discovery Research, Newsantibody development, Antibody Discovery, CAR-T, Novartis, Therapeutic Antibodybiolabs

Great Achievements Have Been Made in Cancer Drug Listing In 2006-2017, a total of 89 oncology therapies (NTDs) were approved by the Center for Drug Evaluation and Research (CDER). The Biologics EvaluationRead More…

08Feb/18

New Monoclonal Antibody Drug Approvals Hit Record Levels in 2017

February 8, 2018Drug Discovery Research, NewsAntibody Discovery, Therapeutic Antibodybiolabs

After more than 30 years of accumulation, monoclonal antibody drugs have become well-deserved mainstream branches in the field of medicine from targets development to technologies improvement. From clinical research to commercialization strategies,Read More…

02Jan/18

Prediction of the World’s Top 10 Best-selling Drugs in 2018

January 2, 2018Drug Discovery Research, NewsDrug information, Therapeutic Antibodybiolabs

Evaluate Pharma, a well-known market research organization in the field of medicine, recently released the report “EP Vantage 2018 Preview”, in which it reviewed the new drug approval in 2017, and predictedRead More…

05Dec/17

What Is the ROI of Anti-cancer Drug R&D? The Latest Research Showed that an Investment of $ 648 Million Can Generate Revenue of $ 1,658 Million

December 5, 2017Drug Discovery Research, NewsAntibody Discovery, Therapeutic Antibodybiolabs

  A new study recently calculated the development costs of 10 new anti-tumor drugs over the 10-year period between 2006 and 2015, and found that the median development time for these 10Read More…

Posts navigation

  • « Previous
  • 1
  • 2
  • 3
  • 4

Categories

  • Antibody Engineering Research
  • Biological Knowledge
  • Drug Discovery Research
  • Immunotherapy Research
  • News

Recent Posts

  • Scientists identify a special gene that produces key antibodies in large quantities
  • The molecular mechanism by which special antibodies protect the body against HIV infection
  • Multispecific antibodies enhance cancer immunotherapy
  • Scientists have cracked HIV’s new way of entering the host cell nucleus, which may lead to new therapeutic drugs
  • Antibody sequencing provides a new path for antibody therapy research

Archives

Contact Us

USA – UK

Copyright © Creative Biolabs Blog
Powered by WordPress , Theme i-max by TemplatesNext.
MENU
  • Drug Discovery Research
  • Immunotherapy Research
  • Antibody Engineering Research